Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 4/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | PTPRC | P08575 | 1/20 | 0.39 |
| ▸ | PARP1 | P09874 | 1/20 | 0.37 |
| ▸ | PGR | P06401 | 4/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.33 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.33 |
| ▸ | KCNK2 | O95069 | 1/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16858238 | 0.98 | PDK2 (0.41) | PDK2TDP1L3MBTL1PTPRCPARP1 | |
| SCHEMBL29789012 | 0.89 | PDK2 (0.50) | PDK2TDP1L3MBTL1PTPRCPARP1 | |
| SCHEMBL4911824 | 0.89 | PDK2 (0.50) | PDK2TDP1L3MBTL1PTPRCPARP1 | |
| SCHEMBL808152 | 0.88 | PDK2 (0.49) | PDK2TDP1L3MBTL1PTPRCPARP1 | |
| SCHEMBL24730449 | 0.86 | KCNK2 (0.39) | PDK2TDP1L3MBTL1PTPRCPARP1 | |
| SCHEMBL4922107 | 0.82 | PGR (0.45) | PDK2TDP1PGRGPR84 | |
| SCHEMBL29473421 | 0.82 | PGR (0.45) | PDK2TDP1PGRGPR84 | |
| SCHEMBL30673333 | 0.82 | PGR (0.45) | PDK2TDP1PGRGPR84 | |
| SCHEMBL24730501 | 0.81 | PGR (0.38) | PDK2L3MBTL1PGR | |
| SCHEMBL24730506 | 0.81 | SLC6A4 (0.38) | PDK2PGRKCNK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230146030-A1 | ARYLAMINE COMPOUND, ELECTRONIC COMPONENT USING SAME AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-05-11 | — | — | US | disclosed |
| US-20230146030-A1 | ARYLAMINE COMPOUND, ELECTRONIC COMPONENT USING SAME AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-05-11 | — | — | US | disclosed |
| WO-2023273416-A1 | ORGANIC COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS | 陕西莱特光电材料股份有限公司 | 2023-01-05 | — | — | WO | disclosed |
| WO-2021213109-A1 | ARYLAMINE COMPOUND, ELECTRONIC COMPONENT USING SAME AND ELECTRONIC DEVICE | 陕西莱特光电材料股份有限公司 (CN) | 2021-10-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230146030-A1 | ARYLAMINE COMPOUND, ELECTRONIC COMPONENT USING SAME AND ELECTRONIC DEVICE | OCIAD2, AOC2, OCIAD1 | PDK2 1893/4885TDP1 1387/4885L3MBTL1 4055/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.